| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from alliance party | 5,572 | - |
| Net cash used in financing activities | -21,410 | -80,853 |
| Effect of foreign exchange rate on cash | -1,471 | -777 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 119,987 | -34,748 |
| Cash and cash equivalents at beginning of period | 118,420 | - |
| Cash and cash equivalents at end of period | 238,407 | - |
Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)